EAM
BHVN icon

Eventide Asset Management’s Biohaven BHVN Stock Holding History

Eventide Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-300,000
Closed -$4.23M – 244
2025
Q2 		$4.23M Sell
300,000
-260,056
-46% -$4.63M 0.07% 144
2025
Q1 		$13.5M Hold
560,056
– – 0.27% 109
2024
Q4 		$20.9M Buy
560,056
+160,229
+40% +$7.48M 0.38% 88
2024
Q3 		$20M Sell
399,827
-234,837
-37% -$9.14M 0.34% 86
2024
Q2 		$22M Buy
634,664
+233,563
+58% +$9.24M 0.38% 84
2024
Q1 		$21.9M Hold
401,101
– – 0.34% 86
2023
Q4 		$17.2M Buy
+401,101
New +$12.5M 0.28% 93
2022
Q4 		– Sell
-506,827
Closed -$74.9M – 147
2022
Q3 		$74.9M Buy
+506,827
New +$3.68M 1.47% 24

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eventide Asset Management's BHVN Position: Q3 2025 in Review

Eventide Asset Management sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 300,000 shares — an estimated $4.23M sold.

Eventide Asset Management first reported a position in BHVN in Q3 2022 and held it in 8 quarters. The position peaked at $74.9M in Q3 2022. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • Eventide Asset Management reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
  • Eventide Asset Management sold 300,000 Biohaven shares in Q3 2025, an estimated $4.23M.
  • Eventide Asset Management first reported a position in Biohaven in Q3 2022 and held it in 8 quarters.
  • Eventide Asset Management's Biohaven position peaked at $74.9M in Q3 2022.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Eventide Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.